Martin Mena, A., Négrier, L., Treizebré, A., Guilbert, M., Bonnaire, L., Daniau, V., . . . Décaudin, B. (2023). Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility. Pharmaceutics, 15(8), 2069. https://doi.org/10.3390/pharmaceutics15082069
Chicago Style (17th ed.) CitationMartin Mena, Anthony, et al. "Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility." Pharmaceutics 15, no. 8 (2023): 2069. https://doi.org/10.3390/pharmaceutics15082069.
MLA (9th ed.) CitationMartin Mena, Anthony, et al. "Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility." Pharmaceutics, vol. 15, no. 8, 2023, p. 2069, https://doi.org/10.3390/pharmaceutics15082069.